Zobrazeno 1 - 10
of 21
pro vyhledávání: '"María D. López-Carmona"'
Autor:
Luis M. Pérez-Belmonte, José David Torres-Peña, María D. López-Carmona, M. Mar. Ayala-Gutiérrez, Francisco Fuentes-Jiménez, Lucía Jorge Huerta, Jaime Alonso Muñoz, Manuel Rubio-Rivas, Manel Madrazo, Marcos Guzmán Garcia, Beatriz Vicente Montes, Joaquim Fernández Sola, Javier Ena, Ruth Gonzalez Ferrer, Carmen Mella Pérez, Carlos Jorge Ripper, Jose Javier Napal Lecumberri, Iris El Attar Acedo, Susana Plaza Canteli, Sara Fuente Cosío, Francisco Amorós Martínez, Begoña Cortés Rodríguez, Pablo Pérez-Martínez, José Manuel Ramos-Rincón, Ricardo Gómez-Huelgas, for the SEMI-COVID-19 Network
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Limited evidence exists on the role of glucose-lowering drugs in patients with COVID-19. Our main objective was to examine the association between in-hospital death and each routine at-home glucose-lowering drug both individually
Externí odkaz:
https://doaj.org/article/075d60a7a4074e35b070c9194fc6a79a
Autor:
Sergio Jansen-Chaparro, María D. López-Carmona, Lidia Cobos-Palacios, Jaime Sanz-Cánovas, M. Rosa Bernal-López, Ricardo Gómez-Huelgas
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD
Externí odkaz:
https://doaj.org/article/eedbdd44b7164bd286186756619f2d22
Autor:
Jaime Sanz-Cánovas, Ricardo Gómez-Huelgas, Miguel Ángel Barbancho, Manuel F. Jiménez-Navarro, María Rosa Bernal-López, María D. López-Carmona, Mercedes Millán-Gómez, Almudena López-Sampalo, Michele Ricci, J.P. Lara, Julio Osuna-Sánchez, Luis M. Pérez-Belmonte
Publikováno v:
Journal of the American Geriatrics Society. 70:862-871
Background There is little evidence on the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in older patients with heart failure. This work analyzed the clinical efficacy and safety of empagliflozin continuation in very old patients with type
Autor:
María Rosa Bernal-López, Luis M. Pérez-Belmonte, Lidia Cobos-Palacios, Ricardo Gómez-Huelgas, María D. López-Carmona, Mónica Muñoz-Úbeda, Jaime Sanz-Cánovas, Almudena López-Sampalo
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
Atherosclerotic cardiovascular diseases (ASCVD) are the leading cause of death worldwide. High levels of total cholesterol—and of low-density lipoprotein cholesterol in particular—are one of the main risk factors associated with ASCVD. Statins ar
Autor:
María D. López-Carmona, Lidia Cobos-Palacios, Jaime Sanz-Cánovas, Sergio Jansen-Chaparro, Ricardo Gómez-Huelgas, M. Rosa Bernal-Lopez
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD
Autor:
María D. López-Carmona, Antonio Vargas-Candela, Jaime Sanz-Cánovas, Maria Isabel Ruiz-Moreno, Lidia Cobos-Palacios, María Rosa Bernal-López, Alberto Vilches-Perez, Javier Benítez-Porres, Mónica Muñoz-Úbeda, Ana Navarro-Sanz, Luis M. Pérez-Belmonte, Ricardo Gómez-Huelgas
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 11926, p 11926 (2021)
International Journal of Environmental Research and Public Health
Volume 18
Issue 22
International Journal of Environmental Research and Public Health
Volume 18
Issue 22
The SARS-CoV-2 pandemic led to lockdowns, which affected the elderly, a high-risk group. Lockdown may lead to weight gain due to increased food intake and reduced physical activity (PA). Our study aimed to analyze the impact of a 12-month lifestyle i
Autor:
Ricardo Gómez-Huelgas, Julio Osuna-Sánchez, M. Rosa Bernal-Lopez, J.P. Lara, Manuel F. Jiménez-Navarro, María D. López-Carmona, Juan José Gómez-Doblas, Jaime Sanz-Cánovas, M. Isabel Ruiz-Moreno, Luis M. Pérez-Belmonte, Mercedes Millán-Gómez, Michele Ricci
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 3540, p 3540 (2021)
Volume 10
Issue 16
Journal of Clinical Medicine, Vol 10, Iss 3540, p 3540 (2021)
Volume 10
Issue 16
There is little evidence on the use of sodium−glucose cotransporter 2 inhibitors in hospitalised patients. This work aims to analyse the glycaemic and clinical efficacy and safety of empagliflozin continuation in patients with type 2 diabetes hospi
Autor:
Ana I. Perez-Caballero, Irwin Jungreis, Juan F. Alcala-Diaz, Marta Entrenas-Castillo, María D. López-Carmona, Luis M. Pérez-Belmonte, Aquiles Lozano Rodríguez-Mancheño, Jose Lopez-Miranda, José Luis Zambrana-García, Roger Bouillon, Laura Limia-Perez, Javier García-Alegría, Begoña Cortés-Rodríguez, Maria del Sol Arenas-de Larriva, María Dolores Martín-Escalante, Ricardo Gómez-Huelgas, Jose Manual Quesada-Gomez
Publikováno v:
Nutrients
Volume 13
Issue 6
Nutrients 13(6), 1760 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Nutrients, Vol 13, Iss 1760, p 1760 (2021)
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Volume 13
Issue 6
Nutrients 13(6), 1760 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Nutrients, Vol 13, Iss 1760, p 1760 (2021)
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Context. Calcifediol has been proposed as a potential treatment for COVID-19 patients. Objective: To compare the administration or not of oral calcifediol on mortality risk of patients hospitalized because of COVID-19. Design: Retrospective, multicen
Autor:
Michele Ricci, M. Rosa Bernal-Lopez, María D. López-Carmona, J.P. Lara, Miguel Ángel Barbancho, Sergio Jansen-Chaparro, Julio Osuna-Sánchez, Luis M. Pérez-Belmonte, Ricardo Gómez-Huelgas, Mercedes Millán-Gómez
Publikováno v:
Panminerva medica.
Older patients managed with intensive antidiabetic therapy are more likely to be harmed. Our study's primary endpoint was to analyze the safety and efficacy of linagliptin in combination with basal insulin versus basal-bolus insulin in patients with
Aging is characterized by a progressive loss of an individual’s functional capacity. The elderly population is biologically heterogeneous, thereby necessitating a comprehensive geriatric assessment that includes functional aspects in the decision-m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcf1ab39771cf73b69cf49055bf2662d
https://doi.org/10.1016/b978-0-12-819667-0.00017-2
https://doi.org/10.1016/b978-0-12-819667-0.00017-2